Utide is a specialized peptide APIs manufacturer with 20,000 m² production facilities in Zunyi, Guizhou, China. Supported by a core team with 20+ years of experience in peptide R&D, process development, and manufacturing, Utide offers strong capabilities in process optimization and rapid scale-up for high-demand peptide products. With the Phase II facility now operational, annual production capacity is expected to reach 1,500–1,800 kg, ensuring stable long-term supply. Utide has obtained U.S. FDA DMFs for tirzepatide (042984) and retatrutide (043330), with additional global filings in progress.

Melos, as Utide’s exclusive strategic partner for Southeast Asia and South Asia, serves as the core platform supporting Utide’s international business development in these markets. Backed by a team with extensive international business and supply chain experience, Melos specializes in providing professional supply solutions and integrated support for high-demand peptides. We are responsible for contract execution, payment settlement, logistics coordination, and customer support, ensuring the smooth, reliable, and compliant delivery of Utide’s high-quality peptide APIs to customers throughout the region.

MELOSBIO

Org chart

Teams

Offices

MELOSBIO

Org chart

Teams

Offices

Related companies